Pelacarsen for reducing the risk of cardiovascular events in people with established cardiovascular disease and hyperlipidaemia [ID6559]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Enlicitide decanoate for treating hyperlipidaemia in people at risk of an atherosclerotic cardiovascular disease event [ID6656]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC